)
Cabaletta Bio (CABA) investor relations material
Cabaletta Bio Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 9, 2026, to be held virtually for shareholders of record as of April 20, 2026.
Shareholders are encouraged to review proxy materials online and may request paper or email copies by May 29, 2026.
Voting matters and shareholder proposals
Election of two Class I directors to serve until the 2029 annual meeting: Scott Brun, M.D., and Shawn Tomasello, MBA.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Amendment to the 2019 Stock Option and Incentive Plan proposed.
Amendment to increase authorized common stock from 300,000,000 to 600,000,000 shares.
Advisory vote on executive compensation (say-on-pay).
Proposal to adjourn the meeting if more time is needed for Proposals 3 and 4.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and all proposals on the agenda.
- Rese-cel delivers durable, safe, outpatient CAR T therapy for autoimmune diseases at scale.CABA
Corporate presentation28 Apr 2026 - Shareholders will vote on key governance, compensation, and capital structure proposals at the annual meeting.CABA
Proxy filing28 Apr 2026 - Six key proposals, including board elections and doubling authorized shares, headline the 2026 proxy.CABA
Proxy filing17 Apr 2026 - Automated manufacturing and outpatient CAR-T therapy drive scalability and cost efficiency.CABA
Guggenheim Securities Emerging Outlook: Biotech Summit 202610 Apr 2026 - Rese-cel delivers transformative, outpatient-ready CAR T therapy for autoimmune diseases.CABA
Corporate presentation23 Mar 2026 - Clinical and manufacturing advances drive progress, with strong cash runway into late 2026.CABA
Q4 202523 Mar 2026 - Automated CAR T manufacturing and no preconditioning may revolutionize autoimmune therapy.CABA
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Pivotal CD19-CAR T trials show strong efficacy, safety, and outpatient potential in autoimmunity.CABA
Corporate presentation12 Feb 2026 - CABA-201 shows strong safety, immune reset, and early efficacy in autoimmune disease trials.CABA
Study Update3 Feb 2026
Next Cabaletta Bio earnings date
Next Cabaletta Bio earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage